248 related articles for article (PubMed ID: 31386864)
1. Serine protease inhibitor AEBSF reduces dengue virus infection via decreased cholesterol synthesis.
Sreelatha L; Malakar S; Songprakhon P; Morchang A; Srisawat C; Noisakran S; Yenchitosomanus PT; Limjindaporn T
Virus Res; 2019 Oct; 271():197672. PubMed ID: 31386864
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
Van der Gucht W; Leemans A; De Schryver M; Heykers A; Caljon G; Maes L; Cos P; Delputte PL
Virol J; 2017 Aug; 14(1):157. PubMed ID: 28818113
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
4. DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target.
Soto-Acosta R; Bautista-Carbajal P; Cervantes-Salazar M; Angel-Ambrocio AH; Del Angel RM
PLoS Pathog; 2017 Apr; 13(4):e1006257. PubMed ID: 28384260
[TBL] [Abstract][Full Text] [Related]
5. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
Tuiskunen A; Wahlström M; Bergström J; Buchy P; Leparc-Goffart I; Lundkvist A
Virol J; 2011 Aug; 8():398. PubMed ID: 21835036
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
9. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target.
Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA
Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774
[TBL] [Abstract][Full Text] [Related]
10. Dengue Virus Targets Nrf2 for NS2B3-Mediated Degradation Leading to Enhanced Oxidative Stress and Viral Replication.
Ferrari M; Zevini A; Palermo E; Muscolini M; Alexandridi M; Etna MP; Coccia EM; Fernandez-Sesma A; Coyne C; Zhang DD; Marques ETA; Olagnier D; Hiscott J
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999020
[TBL] [Abstract][Full Text] [Related]
11. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary Infections.
Soo KM; Khalid B; Ching SM; Chee HY
PLoS One; 2016; 11(5):e0154760. PubMed ID: 27213782
[TBL] [Abstract][Full Text] [Related]
13. Host serine protease ACOT2 assists DENV proliferation by hydrolyzing viral polyproteins.
Ma S; Shi S; Xu B; Liu M; Xie L; Su Y; Li J; Liang Q; Ye S; Wang Y
mSystems; 2024 Jan; 9(1):e0097323. PubMed ID: 38112462
[TBL] [Abstract][Full Text] [Related]
14. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
15. Vivo-morpholino oligomers strongly inhibit dengue virus replication and production.
Phumesin P; Junking M; Panya A; Yongpitakwattana P; Noisakran S; Limjindaporn T; Yenchitsomanus PT
Arch Virol; 2018 Apr; 163(4):867-876. PubMed ID: 29260328
[TBL] [Abstract][Full Text] [Related]
16. Rab18 facilitates dengue virus infection by targeting fatty acid synthase to sites of viral replication.
Tang WC; Lin RJ; Liao CL; Lin YL
J Virol; 2014 Jun; 88(12):6793-804. PubMed ID: 24696471
[TBL] [Abstract][Full Text] [Related]
17. Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression.
Tarasuk M; Songprakhon P; Chimma P; Sratongno P; Na-Bangchang K; Yenchitsomanus PT
Virus Res; 2017 Aug; 240():180-189. PubMed ID: 28864423
[TBL] [Abstract][Full Text] [Related]
18. Episodes of the epidemiological factors correlated with prevailing viral infections with dengue virus and molecular characterization of serotype-specific dengue virus circulation in eastern India.
Rao MRK; Padhy RN; Das MK
Infect Genet Evol; 2018 Mar; 58():40-49. PubMed ID: 29247706
[TBL] [Abstract][Full Text] [Related]
19. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
20. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
